Chenguang Bio-Tech (India) Profile
Key Indicators
- Authorised Capital ₹ 9.00 Cr
as on 17-07-2024
- Paid Up Capital ₹ 9.00 Cr
as on 17-07-2024
- Company Age 14 Year, 2 Months
- Last Filing with ROC 31 Mar 2022
- Revenue 31.64%
(FY 2021)
- Profit 73.32%
(FY 2021)
- Ebitda -141.35%
(FY 2021)
- Net Worth 10.08%
(FY 2021)
- Total Assets 29.94%
(FY 2021)
About Chenguang Bio-Tech (India)
The Company is engaged in the Food And Beverages Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 9.00 Cr and a paid-up capital of Rs 9.00 Cr, as per Ministry of Corporate Affairs (MCA) records.
Lu Qingguo and Qi Lijun serve as directors at the Company.
- CIN/LLPIN
U01403AP2010PTC070338
- Company No.
070338
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
07 Sep 2010
- Date of AGM
30 Sep 2022
- Date of Balance Sheet
31 Mar 2022
- Listing Status
Unlisted
- ROC Code
Roc Vijayawada
Industry
Company Details
- Location
Khammam, Andhra Pradesh, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Chenguang Bio-Tech (India)?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Lu Qingguo  | Director | 07-Sep-2010 | Current |
| Qi Lijun | Director | 03-Jan-2011 | Current |
Financial Performance and Corporate Structure Insights of Chenguang Bio-Tech (India).
Chenguang Bio-Tech (India) Private Limited, for the financial year ended 2021, experienced significant growth in revenue, with a 31.64% increase. The company also saw a substantial improvement in profitability, with a 73.32% increase in profit. The company's net worth Soared by an impressive increase of 10.08%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Chenguang Bio-Tech (India)?
In 2022, Chenguang Bio-Tech (India) had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Chenguang Natural Extracts (India) Private Limited
Active 9 years 6 monthsLu Qingguo is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Chenguang Bio-Tech (India)?
Chenguang Bio-Tech (India) has a workforce of 60 employees as of Mar 30, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Chenguang Bio-Tech (India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Chenguang Bio-Tech (India)'s trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
